Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Muik

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
Ligand Coupling to the AAV Capsid for Cell-Specific Gene TransferJohanna Reul, Alexander Muik, Christian J Buchholz
Expert Review of Vaccines|April 5, 2024
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summaryShanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines|July 7, 2023
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron eraShanti Pather, Alexander Muik, Ruben Rizzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effectEllen Preuss, Alexander Muik, Kristoffer Weber, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2012
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapyAlexander Muik, Catherine Dold, Yvonne Geiß, et al.
The Journal of Gene Medicine|August 1, 2012
Comparison of three humanized mouse models for adoptive T cell transferAndreas Volk, Sylvia Hartmann, Alexander Muik, et al.
Frontiers in Immunology|June 28, 2023
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccinesShanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Mbio|March 30, 2022
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 VaccinesGary McLean, Jeremy Kamil, Benhur Lee, et al.
Frontiers in Immunology|June 8, 2023
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccinesShanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Biomaterials|August 22, 2017
Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transferAlexander Muik, Johanna Reul, Thorsten Friedel, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
Ligand Coupling to the AAV Capsid for Cell-Specific Gene TransferJohanna Reul, Alexander Muik, Christian J Buchholz
Expert Review of Vaccines|April 5, 2024
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summaryShanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines|July 7, 2023
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron eraShanti Pather, Alexander Muik, Ruben Rizzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effectEllen Preuss, Alexander Muik, Kristoffer Weber, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2012
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapyAlexander Muik, Catherine Dold, Yvonne Geiß, et al.
The Journal of Gene Medicine|August 1, 2012
Comparison of three humanized mouse models for adoptive T cell transferAndreas Volk, Sylvia Hartmann, Alexander Muik, et al.
Frontiers in Immunology|June 28, 2023
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccinesShanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Mbio|March 30, 2022
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 VaccinesGary McLean, Jeremy Kamil, Benhur Lee, et al.
Frontiers in Immunology|June 8, 2023
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccinesShanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Biomaterials|August 22, 2017
Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transferAlexander Muik, Johanna Reul, Thorsten Friedel, et al.
Pageof 5